Mass spectrometry (MS) has been widely used to analyze biological samples and has evolved into an indispensable tool for proteomics. 1, 2) In the MS technology, improvements in mass spectrometers have been a central field of investigation.
Mass spectrometry (MS) has been widely used to analyze biological samples and has evolved into an indispensable tool for proteomics. 1, 2) In the MS technology, improvements in mass spectrometers have been a central field of investigation. 3) Among them, ion-trap mass spectrometers are robust, sensitive, and relatively inexpensive, such that they have produced much of the proteomics data reported in the literature. 3, 4) Quantitative proteomics is widely used not only for examining differences in global protein expression between cellular states but also for exploring disease biomarkers and drugtargets. 5, 6) After having discovered proteins bearing interesting changes between samples, the results should be verified by targeted quantification of the proteins. For such a targeted quantitative proteomics using mass spectrometers, selected reaction monitoring (SRM) is becoming a popular approach. SRM is the technique to monitor target-specific fragmentation transition from a precursor ion to a product ion, so that the background could be reduced to allow lower detection limit and higher specificity. 6, 7) It is generally accepted that triple-quadrupole mass spectrometers are the instrument of choice for such a targeted quantitative analysis, because of their high duty cycle and wide dynamic range for in tandem mass spectrometry. On the other hand, ion-trap mass spectrometers have been considered difficult to be applied to such a targeted quantitative proteomics. It has been thought that their small trapping volume makes ion-trap mass spectrometers have only a limited capacity for ion storage and narrow dynamic range of quantification. 4) Recently, however, it was reported that SRM performed with a linear ion-trap (LIT) mass spectrometer is rather more appropriate to analyze large peptides than the triple quadrupole ones. 8) LIT is an improved version of ion-trap enabling increased ion storage capacity and enhanced trapping efficiency. 9) In that reported study, large peptides [glucagon-like peptide (molecular weight (MW) 3089 Da) and exendin-4 (MW 4185 Da)] and a small peptide [vasopressin (MW 1084 Da)] were analyzed by SRM MS conducted with both LIT and triple-quadrupole mass spectrometers for comparison. 8) Due to the difference in collision-induced dissociation (CID) processes, both types of mass spectrometers often generate significantly different fragmentation spectra of product ion species with different intensity patterns. In triple-quadrupoles, peptide ions are accelerated through a pressurized collision cell containing typically argon or nitrogen gas. In this CID condition, product ions do not loose their accelerated kinetic energy, leading to a collision cascade or a multiple-step fragmentation. This results in the generation of a large number of product ions thus the presence of relatively low abundance of analyte ions. In contrast, CID in LIT proceeds in the field containing helium gas by applying resonance excitation frequency matched to m/z of the precursor ion, such that only a single-step fragmentation occurs because the product ions are no longer in resonance with the excitation frequency. Since fewer sorts of fragment ions with higher relative abundance are generated from large peptide analytes in the LIT mass spectrometer than those generated in the triple-quadrupole one as described above, a lower detection limit of peptides can be observed with the former one. Although these results suggest that SRM MS with an LIT mass spectrometer should be suitable for peptide analysis, it should be confirmed that the LIT mass spectrometer can perform multiple SRM analyses, which ability would be especially useful for efficient verification of discovered candidate proteins.
Another issue concerning proteomic application of SRM MS is the way of absolute quantification of peptides, because determination of the absolute concentration of proteins (or Selected reaction monitoring (SRM) mass spectrometry (MS) is becoming a popular approach for targeted quantitative proteomics. Triple-quadrupole mass spectrometers have been historically considered as the instrument of choice for this type of quantitative analysis. Recently, however, it has been reported that the SRM MS with a linear ion-trap (LIT) mass spectrometer is rather more appropriate for quantitative analysis of large peptides than the triple-quadrupole ones. In this study, we demonstrate that the SRM MS performed with a LIT mass spectrometer can simultaneously analyze multiple peptides and can quantify specific peptides in biological specimens without the use of stable isotope (SI)-labeled standard peptides. Firstly, a mixture of 10 synthesized peptides derived from yeast proteins and bovine serum albumin (BSA) was simultaneously analyzed by the LIT SRM. The ion peak areas of the 10 peptides were linearly correlated with the input amounts between 1 fmol and 10 pmol. Furthermore, the same peptide mixture spiked into human plasma was analyzed, and a linear response was found. Next, the amount of a BSA tryptic peptide was quantified by using an SI-labeled or a non SI-labeled peptide as an external reference standard. The difference in the quantified amounts of the BSA tryptic peptide was less than 10% between the 2 methods, suggesting that the "externally pulsed" non SI-labeled standard peptides derived from another species are useful. These results indicate that the SRM MS conducted with a LIT mass spectrometer is applicable to targeted quantitative proteomics of peptides at least up to 10 in number.
peptides) present within a complex sample is important for quantitative evaluation of candidate proteins discovered by exploratory proteomics studies. A typical method for absolute quantification of compounds, e.g., HPLC, employs one or more external reference compounds to generate a calibration response curve for quantification. The absolute quantification of the target compound is then determined by comparing the observed signal response of the specific compound in the sample with that of calibration response curve. However, for the multiple absolute quantification of a number of different candidate peptides by SRM MS, multiple separate calibration curves are required for each specific peptide. Although it is ideal to use calibrants directly added to the study samples to minimize the effect of measurement-to-measurement variation, it is impossible to add target peptides themselves as calibrants because of the difficulty of discriminating signals from intrinsic and externally applied peptides. A conventional technique to determine absolute quantification of proteins (or peptides) involves the use of synthesized peptides labeled with stable isotope (SI) corresponding to their native counterparts formed by proteolysis as a reference standard spiked into the mixture. 10, 11) This allows direct correlation between the SI-labeled peptide and its naturally occurring analog. A drawback of the use of SI-labeled peptides is the high cost to synthesize them, which may become a major issue if large numbers of the SI-labeled peptides are required. If non-SI-labeled peptides instead of SI-labeled ones can be used as calibrants, such a problem is thought to be solved.
In the present study, we demonstrate the feasibility of using multiple SRM MS performed with a LIT mass spectrometer for simultaneous quantitative assays of multiple peptides. Furthermore, we also demonstrate that an absolute quantification of multiple peptides by using non-SI-labeled external reference peptides is possible by comparing the results obtained by using both non-and SI-labeled standards. These results indicate that the LIT mass spectrometer might also be applicable to quantitative proteomics with multiple SRM.
MATERIALS AND METHODS
Peptides Bovine serum albumin (BSA) tryptic digest was purchased from Michrom Bioresources (Auburn, CA, U.S.A.). Synthesized peptides used in this study were purchased from Sigma-Genosys (Ishikari, Japan). Nine of the 10 peptides used were derived from yeast proteins (ADH1, ADH2, ADH3, ADH4, ADH5, PGI1, PGI2, PGI3, and PGI4) and the other was from BSA (BSA-3). The amino acid sequence, mass, and SRM transition of the peptides are listed in Table 1 . The peptide sequences of these peptides are unique and not overlapping with any human protein. The peptides were dissolved in dimethylsulfoxide (DMSO; Wako Pure Chemical, Osaka, Japan) at 10 mM and stocked at Ϫ20°C. For LC/MS analyses, the dissolved peptides were further diluted with a solution consisting of DMSO : (2% acetonitrile (ACN) and 0.1% trifluoroacetic acid (TFA))ϭ 50 : 50.
An SI-labeled synthesized peptide derived from a BSA tryptic peptide (LVNELTEF*AK: F* was labeled with [ Human Plasma Depletion and Tryptic Digestion Human plasma, which contained 3.8% trisodium citrate as anticoagulant and was in lyophilized form, was purchased from Sigma-Aldrich and dissolved in Milli-Q water. Albumin and immunoglobulin G (IgG) were depleted from the plasma by using an Albumin and IgG removal resin (GE Healthcare, Waukesha, WI, U.S.A.) according to the manufacturer's instructions.
An aliquot of the depleted human plasma (200 mg protein) was denatured in 50% ACN and 100 mM NH 4 HCO 3 at 37°C for 60 min, and was then reduced in 50 mM Tris(2-carboxyethyl)phosphine, 25% ACN, and 100 mM NH 4 HCO 3 at 37°C for 45 min. The protein was then alkylated in the dark at room temperature for 60 min in a solution of 250 mM iodoacetamide, 25% ACN, and 100 mM NH 4 HCO 3 . A sequence grade modified trypsin (Promega, Madison, WI, U.S.A.) was added to 1 aliquot (protease : protein ratioϭ1 : 50), and the mixture was incubated at 37°C for 16 h. The trypsin-digested human plasma was stocked at Ϫ80°C prior to use. ; where mobile phase A was 2% ACN with 0.1% formic acid (FA) and mobile phase B was 90% ACN with 0.1% FA.
LC/MS Conditions
The SRM transitions set for the peptides are listed in Table  1 , and SRM was carried out with normal collision energyϭ 35%, 1 microscan, 100 ms ion time.
Peak area integration was accomplished by using an Xcalibur (version 2.0.7 SP1) data analysis software (Thermo Fisher Scientific).
Absolute Quantification of Peptide For absolute quantification analyses, the BSA tryptic digest (Michrom Bioresources) was used as a model sample. The digest was diluted 136 Vol. 34, No. 1 with 2% ACN and 0.1% TFA to 1 pmol ml
Ϫ1
, and further diluted with a solution of DMSO : (2% ACN and 0.1% TFA)ϭ 50 : 50 to 1, 5, 10, 50, or 100 fmol ml Ϫ1 (the amounts as BSA protein concentration).
Among the trypsin-digested BSA peptides, 1 peptide ( 66 LVNELTEFAK 75 , the amino acid number was denoted from UniProtKB/Swiss-Prot accession number P02769) was selected as a model peptide to be absolutely quantified.
Quantification Using Stable Isotope-Labeled Externally Applied Reference Peptide The outline of the method using SI-labeled peptide is shown in Fig. 1A . Serially diluted BSA tryptic digest (1, 5, 10, 50 or 100 fmol) was coincidently applied with the SI-labeled BSA peptide (100 fmol) to the reverse-phase column. The SRM transitions used were m/z 587.4 (2ϩ charge state)→961.4 and m/z 582.5 (2ϩ)→951.4 for the SI-labeled peptide and for the native form, respectively. The amount of the native form of the peptide, LVNELTEFAK, derived from BSA (A native ) was quantified by the following formula:
where A native , A SIpulsed , PA native , and PA SIpulsed are the amount of native form of BSA peptide, amount of pulsed SI-labeled BSA peptide, peak area of native form of BSA peptide, and peak area of pulsed SI-labeled peptide, respectively.
Quantification Not-using Stable Isotope-Labeled Externally Applied Reference Peptides The scheme of the method not using stable-isotope labeled peptides is shown in Fig. 1B . The mixture of non-stable isotope-labeled reference peptides consisted of PGI1, PGI4, ADH1, ADH3, ADH5, and PGI2 (Table 1 ). The peptide derived from the native form BSA tryptic peptide (LVNELTEFAK) was also synthesized (BSA-3). The absolute quantification of the BSA tryptic peptide (LVNELTEFAK) was carried out via the following steps: STEP 1) A signal response factor ratio (F target/reference ) between the target peptide (BSA-3) and the reference peptide (ADH3) was determined. The signal response factor ratio was defined as the peak-area ratio of BSA-3 to the same amount of externally applied reference peptide (ADH3).
STEP 2) The serially diluted BSA tryptic digests (1, 5, 10, 50, or 100 fmol) were coincidently applied with the reference peptide mixture (1000 fmol) to the reverse-phase column. The SRM transitions used were m/z 582.5 (2ϩ charge state)→951.4 and m/z 484.9 (2ϩ charge state)→540.6 for the native-form BSA tryptic peptide (LVNELTEFAK) and for the external reference peptide (ADH3), respectively. The amount of the native form BSA tryptic peptide (A target ) was calculated by the following equation using analyzed peak areas and the signal response factor ratio mentioned above:
where A target , A reference , PA target , PA reference , and F target/reference are the amount of target peptide, amount of pulsed reference peptide, peak area of target peptide, peak area of pulsed reference peptide, and signal response factor ratio, respectively.
RESULTS AND DISCUSSION

SRM Mass Spectrometry with Linear Ion Trap for Quantification of Multiple Peptides
Recently, it was reported that quantitative analysis of peptides could be carried out by using a LIT mass spectrometer in the SRM mode and that the LIT could achieve lower limit of quantification for peptides than triple-quadrupole instruments due to their more efficient CID process. 8) Because multiple peptides of interest need to be assayed in a quantitative proteomics study at the verification phase of study, multiple SRM MS analyses for multiple peptides are required. Therefore, in this study, simultaneous analyses of multiple peptides using the SRM MS with a LIT mass spectrometer were examined.
At first, the mixture of 10 synthesized peptides (Table 1 ) was prepared as a model sample and was analyzed by the LTQ LIT mass spectrometer. Figure 2 shows typical mass stectra and chromatograms of this study. Figure 2A (A) A known amount of SI-labeled peptide having its sequence identical to that of the target peptide is concurrently analyzed with the target peptide. Because both peptides have the same chemical property, they are eluted at the same retention time on HPLC, whereas the peptides can be separated by mass spectrometry (MS) because of their different masses. The peak areas of them are determined by SRM MS, so that the absolute amount of target peptide can be calculated based on the peak areas and the known input amount of SI-labeled peptide. (B) The method not-using SI-labeled peptide consists of 2 steps. STEP 1: A ratio of peak areas of the same amount of target peptide and the reference peptide are determined (signal response factor ratio). In this scheme, reference peptide A is selected because of its closest retention time to that of the target peptide (surrounded by the dotted square). STEP 2: The absolute amount of target peptide in the sample is calculated by the formula described in the figure.
Vol. 34, No. 1 MS/MS spectrum of the m/z 582.5 shows that m/z 951.4 is the most abundant fragment peak (Fig. 2B) . These precursor (m/z 582.5) and product (m/z 951.4) ions were set for the SRM transition for BSA-3 peptide (Table 1) . Likewise, the SRM transitions for the other 9 peptides were determined ( Table 1 ). Figure 2C shows a typical base peak MS chromatogram of the mixture of these 10 peptides (injection amountϭ1 pmol each), whereas Fig. 2D is the chromatogram of the same peptides mixture in the presence of 1 mg tryptic digest of human plasma as a complex matrix, indicating difficulty to discriminate pulsed peptides. By using SRM in LIT mass spectrometer, however, BSA-3 peptide can be clearly separated and quantified both in the presence and absence of the complex plasma matrix (Figs. 2E, F) .
The 10-peptide mixture was diluted to 1, 10, 100, 1000 or 10000 fmol ml
Ϫ1
. The peak area of each peptide was calculated with the built-in peak area integration feature of the Xcalibur data analysis software. The quantitative assays for the 10 peptides showed excellent linearity, reproducibility, and low limit of quantification (LOQ, Fig. 3 , closed lozenges with solid lines). Here, the LOQs were determined as the lowest amounts of peptides whose peak areas could be automatically integrated by the Xcalibur. Linearities were observed over 4 orders of magnitude (from 1 fmol to 10 pmol), and LOQs of 1 fmol on-column were achieved. These results are comparable to those of an earlier study using the SRM with LIT, where the calibration curves of glucagon-like peptide (GLP-1) showed 3 orders from 30 pM (corresponds to 2 pg on-column) to 60 nM. 8) Next, we tried to detect peptide mixture pulsed into a complex biological sample. The 10-peptide mixture was serially diluted and added to trypsin-digested human plasma as a model of a complex biological sample. The diluted peptide mixture (1, 10, 100, 1000, or 10000 fmol) was analyzed with 1 mg of the digested plasma protein. Figure 3 shows that all 10 peptides added to the trypsinized human plasma could be detected and that their response linearity depended on the input amount (open squares with dashed lines). Although Fig. 3 shows linear dependence up to 10 pmol as in the condition without plasma matrix, the LOQs of some peptides did not reach to 1 fmol. This result suggests that ion suppression by the coexisting large amount of plasma peptides might weaken the intensity of them. However, these results also show that such ion suppression does not influence the linearity of the peak intensity even in the presence of plasma matrix, indicating the usefulness of the SRM MS with a LIT mass spectrometer for complex mixture of biological samples. These results indicate that simultaneous analysis using the SRM MS with an ion-trap mass spectrometer is feasible up to 10 peptides and is suitable for the quantitative assay of multiple peptides in a complex sample.
It has been considered that the triple quadrupole mass spectrometers are suitable for quantitative analysis of small molecules because of their high sensitivity, precision, and accuracy, especially for simultaneous analysis of multiple analytes. Shipkova et al., 8) however, mentioned that although most peptide quantitative studies reported in the literature also have followed this trend, the advantages of triple quadrupoles for quantification of small molecules can not always be applicable to peptides. Their study further demonstrated that the LIT mass spectrometer is superior to the triple-quadrupole one for analysis of large peptides because multiple-step fragmentation of large peptides is inevitable in the latter. Although the limited capacity for ion storage due to their small trapping volume has been considered a disadvantage of ion traps, recent advances in MS technology including LIT have enabled the capacity of traps to be enlarged. 9) Furthermore, the number of ions introduced into the trap can be controlled automatically by the automatic gain control, so that good management for quantitative analyses of small number of peptides has become possible. Taken together, the LIT mass spectrometer can be considered an alternative instrument for simultaneous SRM assays, though the number of simultaneously assayable peptides might be limited compared to the same assay with triplequadrupole ones. Estimation of Quantification Limit of Protein Concentration Level in Human Plasma Using the SRM MS with LIT Because in 8 of 10 peptides we could quantify 1 fmol peptide in a 1-mg plasma protein digest (Fig. 3) , ideally 1 fmol of protein (corresponding to 50 pg, if its molecular weightϭ50000) can be considered to be detected after digestion of 1 mg of protein, i.e., 1/20000 of the input protein amount. Therefore, because the plasma protein concentration can be assumed to be about 70 mg/ml, when plasma proteins are injected after digestion without depletion of highly abundant proteins, proteins above 3.5 mg/ml will be quantified; and when plasma proteins after depletion of albumin and IgG (assuming 75% of total proteins) are injected, about 0.875 mg/ml will be the lower quantification limit.
The estimated concentration range in original plasma is classified as "classical plasma proteins" described in Anderson and Anderson.
12) Comparable to our result, a mg/ml level of protein in plasma (0.67 mg ml Ϫ1 of L-selectin) has been reported to be quantifiable by using a 4000 Q Trap hybrid triple-quadrupole/linear ion trap-type mass spectrometer. 13) However, since many protein biomarkers of clinical currency are present at or below the ng/ml range in plasma, the sensitivity of LIT SRM MS still needs to be enhanced, and also improvement of sample preparation and LC separation methods will be needed. For example, 2-dimensional LC separation might be useful to detect low-level proteins in plasma (ng/ml range) by SRM, as was demonstrated by Keshishian et al.
14)
Absolute Quantification of the BSA Tryptic Peptide by Using the SRM MS Finally, we examined the possibility of absolute quantification of target peptides without SI-labeled reference peptides. For this purpose, we compared the 2 methods, with and without SI-labeled reference peptides, to absolutely quantify a model peptide derived from a BSA tryptic digest, i.e., LVNELTEFAK.
Firstly, we quantified the amount of the model peptide in the BSA tryptic digest by using an SI-labeled reference peptide. After SRM measurements of the mixture of serially diluted tryptic digests of BSA and an SI-labeled reference peptide (100 fmol), the amount of native form of LVNELTE-FAK was determined as described in Materials and Methods. The quantified amount of the peptide in 5, 10, 50, and 100 fmol of the BSA tryptic digest were 5.6, 10.8, 54.4, and 121.8 fmol, respectively (Table 2) .
For quantification without SI-labeled reference peptides, we firstly determined the "signal response factor ratio." Because different peptides have different propensities for ionization, 2 different peptides present in equimolar amounts would show substantially different intensities in the mass spectra. Therefore, the peak area ratio of the target peptide and the external reference peptide was required. Because ADH3 had close retention time to BSA-3 (ADH3, about 45 min; BSA-3, about 40 min), ADH3 was chosen here as the external reference peptide to be used for the quantification of the BSA-3 peptide. The mixture of synthesized peptide of the native form (BSA-3) and the external reference peptide (10, 100 or 1000 fmol) was analyzed by the SRM MS in duplicate, and the mean value of the peak area ratio (BSA-3/ADH3) was determined to be 3.68 from the obtained peak areas (Table 3) . By using this "signal response factor ratio," the amounts of the BSA tryptic peptide (LVNELTEFAK) in the serially diluted BSA tryptic digest (5, 10, 50, 100 fmol) were determined using 1 pmol of ADH3 as the reference. The absolute quantification values of the native-form BSA tryptic peptides in 5, 10, 50, and 100 fmol of BSA tryptic digest were 6.0, 12.0, 57.1, and 120.4 fmol, respectively (Table  4) . In Table 4 , the %-differences in these values compared with those determined with the SI-labeled reference peptide (Table 3) are also depicted, indicating low %-differences be- 
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a) Injected amount of the peptides. All injections were performed in duplicate. b) Area was analyzed by Xcalibur. c) Average, standard deviation (S.D.), and % coefficient of variation (CV%) of the BSA-3/ADH3 area ratio. Average value was used as the "signal response factor ratio." tween these 2 quantification methods. These results taken together show that these 2 absolute quantification methods are both applicable to absolutely quantify the peptide amount by SRM. Although this model study was performed using BSA tryptic digests without complex biological matrix, the wide linear range of SRM MS quantification even in the presence of plasma matrix (Fig. 3) might support the applicability of this method in the presence of complex biological matrix. When ion suppression of small signal occurs, underestimation of peptide concentrations will be unavoidable irrespective of the use of SI-labeled reference peptides. Therefore our method is thought to be comparable to that with SIlabeled one in the presence of complex biological matrix.
An advantage of the method without SI-labeled external reference peptides might be its lower cost than that using the SI-labeled ones. Another merit is its versatility, since a predetermined set of reference peptides spanning a wide range of retention times can work for a variety of target peptides, provided that non-SI-labeled target peptides are prepared. Furthermore, using the same platform both at discovery and verification phases will be more efficient to select appropriate SRM transition pairs than separately using LIT and triple-quadrupole MS spectrometers at discovery and verification phases, respectively. 15) On the other hand, its disadvantage might be the extra 1 step required to determine the signal response factor ratio. However, at the verification phase of a proteomics study, unbiased comparison between samples is more important than "absolute" quantification of target peptides. For this purpose, the signal response factor ratio is not necessary, and therefore the extra 1 step mentioned above would not be required.
CONCLUSION
In this study we found that an LIT mass spectrometer in the SRM mode can be applied to analyze multiple peptides (at least up to 10) simultaneously. Furthermore, we also found that it was possible to absolutely quantify target peptides without SI-labeled reference peptides with accuracy comparable to that using the method with SI-labeled reference peptides. These results taken together indicate that if proteins or peptides of interest are small in number, the LIT mass spectrometer is a very powerful tool for quantitative proteomics using SRM MS assays, offering a rapid and costeffective path to the confirmation of results obtained from discovery-based methods.
